SecBot SecBot

HNPHY

Hansoh Pharmaceutical Group Co Limited
OTC· CIK 0002073669 Biotech & Drug Discovery
—

Price

Daily candles with volume.

Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent
Jun 1, 2026
Trial readout
T-90d Trial Readout: HS-20093 (Phase 3)
Trial: Study of HS-20093 Versus Gemcitabine in Combination With Docetaxel in Treatment of Osteosarcoma After Previous Second-line Treatment Failure…
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Jun 1, 2026 Clinical trial readout
T-90d Trial Readout: HS-20093 (Phase 3)
Trial: Study of HS-20093 Versus Gemcitabine in Combination With Docetaxel in Treatment of Osteosarco